AU1357501A - Method and compositions for treating pulmonary diseases - Google Patents

Method and compositions for treating pulmonary diseases Download PDF

Info

Publication number
AU1357501A
AU1357501A AU13575/01A AU1357501A AU1357501A AU 1357501 A AU1357501 A AU 1357501A AU 13575/01 A AU13575/01 A AU 13575/01A AU 1357501 A AU1357501 A AU 1357501A AU 1357501 A AU1357501 A AU 1357501A
Authority
AU
Australia
Prior art keywords
pde
rolipram
compounds
asthma
pde4
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13575/01A
Other languages
English (en)
Inventor
Peter N. Goodfellow
Richard Nieman
Theodore J. Torphy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU1357501A publication Critical patent/AU1357501A/en
Priority to AU2004205324A priority Critical patent/AU2004205324A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU13575/01A 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases Abandoned AU1357501A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2004205324A AU2004205324A1 (en) 1999-11-02 2004-08-30 Method and compositions for treating pulmonary diseases

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
US60163158 1999-11-02
PCT/US2000/030113 WO2001032127A2 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2004205324A Division AU2004205324A1 (en) 1999-11-02 2004-08-30 Method and compositions for treating pulmonary diseases

Publications (1)

Publication Number Publication Date
AU1357501A true AU1357501A (en) 2001-05-14

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13575/01A Abandoned AU1357501A (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Country Status (29)

Country Link
EP (1) EP1225866A4 (pt)
JP (1) JP2003513028A (pt)
KR (1) KR20020057988A (pt)
CN (1) CN1387404A (pt)
AP (1) AP2002002496A0 (pt)
AR (1) AR029189A1 (pt)
AU (1) AU1357501A (pt)
BG (1) BG106748A (pt)
BR (1) BR0015270A (pt)
CA (1) CA2388333A1 (pt)
CO (1) CO5261512A1 (pt)
CZ (1) CZ20021512A3 (pt)
DZ (1) DZ3225A1 (pt)
EA (1) EA200200518A1 (pt)
EC (1) ECSP003747A (pt)
HK (1) HK1049107A1 (pt)
HU (1) HUP0203152A3 (pt)
IL (1) IL149367A0 (pt)
MA (1) MA26841A1 (pt)
MX (1) MXPA02004350A (pt)
NO (1) NO20022057L (pt)
OA (1) OA12076A (pt)
PE (1) PE20011005A1 (pt)
PL (1) PL355261A1 (pt)
SK (1) SK7592002A3 (pt)
TR (1) TR200201211T2 (pt)
TW (1) TWI242431B (pt)
WO (1) WO2001032127A2 (pt)
ZA (1) ZA200203435B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100496607C (zh) * 2001-09-19 2009-06-10 尼科梅德有限责任公司 Nsaid与pde-4抑制剂的并用药物
CA2462525A1 (en) * 2001-10-31 2003-05-08 Merck Patent Gesellschaft Mit Beschraenkter Haftung Type 4 phosphodiesterase inhibitors and uses thereof
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
US20060199789A1 (en) * 2003-03-31 2006-09-07 Kyowa Hakko Kogyo Co., Ltd. medical composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
JPWO2006041121A1 (ja) * 2004-10-13 2008-05-15 協和醗酵工業株式会社 慢性皮膚疾患の治療および／または予防剤
EP1948167A1 (en) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Compositions of phosphodiesterase type iv inhibitors
MY187036A (en) 2010-01-05 2021-08-27 Microdose Therapeutx Inc Inhalation device and method
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7174794A (en) * 1993-06-18 1995-01-17 Smithkline Beecham Corporation Compounds
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
JP2003513028A (ja) 2003-04-08
SK7592002A3 (en) 2002-11-06
CZ20021512A3 (cs) 2003-04-16
HUP0203152A3 (en) 2004-06-28
DZ3225A1 (fr) 2001-05-10
EA200200518A1 (ru) 2002-10-31
MXPA02004350A (es) 2002-11-07
TWI242431B (en) 2005-11-01
ECSP003747A (es) 2002-05-23
CO5261512A1 (es) 2003-03-31
WO2001032127A3 (en) 2001-12-06
KR20020057988A (ko) 2002-07-12
BG106748A (en) 2003-02-28
NO20022057L (no) 2002-06-27
MA26841A1 (fr) 2004-12-20
PL355261A1 (en) 2004-04-05
CN1387404A (zh) 2002-12-25
IL149367A0 (en) 2002-11-10
WO2001032127A2 (en) 2001-05-10
EP1225866A2 (en) 2002-07-31
ZA200203435B (en) 2003-06-25
CA2388333A1 (en) 2001-05-10
AR029189A1 (es) 2003-06-18
HUP0203152A2 (hu) 2003-01-28
TR200201211T2 (tr) 2002-08-21
AP2002002496A0 (en) 2002-06-30
NO20022057D0 (no) 2002-04-30
EP1225866A4 (en) 2004-04-21
BR0015270A (pt) 2002-06-18
PE20011005A1 (es) 2001-09-28
OA12076A (en) 2006-05-04
HK1049107A1 (zh) 2003-05-02

Similar Documents

Publication Publication Date Title
US20050070514A1 (en) Therapies for treating respiratory diseases
US6555583B2 (en) Therapies for treating pulmonary diseases
US20040180918A1 (en) Novel therapeutic method
CZ219196A3 (en) Application of mometasonfuorate aqueous suspension for preparing a medicament for effective intranasal treatment of nasal allergy
US20040176419A1 (en) Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases
AU1357501A (en) Method and compositions for treating pulmonary diseases
US20060035877A1 (en) Method and compositions for treating pulmonary diseases
AU2001279023B2 (en) Method for reducing exacerbations associated with COPD
JP2005508963A (ja) 喘息を治療するためのサルメテロールとフルチカゾンプロピオネートを含む医薬の組み合せ
AU2003292120B2 (en) New synergistic combination comprising roflumilast and formoterol
AU7205701A (en) Method and compositions for treating an inflammatory disease
AU2004205324A1 (en) Method and compositions for treating pulmonary diseases
EP1261331A1 (en) Method and compositions for treating fibrotic diseases
KR20050094810A (ko) 로플루미래스트와 ｒ,ｒ-포르모테롤을 포함하는 상승작용성조합물
AU2002310620A1 (en) Composition comprising a PDE-4 inhibitor and H1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment respiratory diseases
TW202428261A (zh) 用於治療重症肌無力的組成物與方法
Crompton Asthma: management
AU2002321261A1 (en) Use of a PDE4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted